{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T09:45:01Z","timestamp":1791193501575,"version":"4.1.0"},"reference-count":9,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2005,3,1]],"date-time":"2005-03-01T00:00:00Z","timestamp":1109635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2005,3]]},"DOI":"10.1016\/j.transproceed.2005.01.079","type":"journal-article","created":{"date-parts":[[2005,4,21]],"date-time":"2005-04-21T07:40:57Z","timestamp":1114069257000},"page":"1355-1359","source":"Crossref","is-referenced-by-count":8,"title":["C2 and C0 Values for Monitoring Cyclosporine Therapy in Stable Heart Transplant Recipients"],"prefix":"10.1016","volume":"37","author":[{"given":"F.","family":"Diciolla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Scolletta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Berti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Maccherini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Federici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Bernazzali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Lisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Chiavarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2005.01.079_bib1","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1097\/00007890-199912270-00003","article-title":"Clinical benefit of neoral dose monitorino with cyclosporine 2-hr post-dose levels compared with trough levels in stable heart transplant patients","volume":"68","author":"Cantarovich","year":"1999","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2005.01.079_bib2","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1034\/j.1399-0012.2003.00036.x","article-title":"Impact of cyclosporine 2-h level and mycophenolate mofetil dose on clinical outcomes in de novo heart transplant patients receiving anti-thymocyte globulin induction","volume":"17","author":"Cantarovich","year":"2003","journal-title":"Clin Transplant"},{"key":"10.1016\/j.transproceed.2005.01.079_bib3","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1097\/00007890-200203270-00022","article-title":"Improved clinical outcomes for liver transplant recipients using cyclosporine monitoring based on 2 h post-dose levels (C2)","volume":"73","author":"Levy","year":"2002","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2005.01.079_bib4","doi-asserted-by":"crossref","first-page":"S162","DOI":"10.1097\/00007890-200004271-00190","article-title":"Neoral phase IV Study Group","volume":"69","author":"Barama","year":"2000","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2005.01.079_bib5","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/00007890-199609150-00010","article-title":"Variable oral absorption of cyclosporine: a biopharmaceutical risk factor for chronic renal allograft rejection","volume":"62","author":"Kahan","year":"1996","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2005.01.079_bib6","doi-asserted-by":"crossref","first-page":"45S","DOI":"10.1016\/S0041-1345(00)00863-0","volume":"32","author":"Belitsky","year":"2000","journal-title":"Tranplant Proc"},{"key":"10.1016\/j.transproceed.2005.01.079_bib7","doi-asserted-by":"crossref","first-page":"53S","DOI":"10.1016\/S0041-1345(00)00864-2","volume":"32 (Suppl)","author":"Johnston","year":"2000","journal-title":"Tranplant Proc"},{"key":"10.1016\/j.transproceed.2005.01.079_bib8","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2165\/00063030-200115050-00001","volume":"15","author":"Levy","year":"2001","journal-title":"Biodrugs"},{"key":"10.1016\/j.transproceed.2005.01.079_bib9","volume":"671133","author":"Grant","year":"1999","journal-title":"Tranplantation"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134505001089?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134505001089?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,26]],"date-time":"2019-01-26T20:25:34Z","timestamp":1548534334000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134505001089"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3]]},"references-count":9,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,3]]}},"alternative-id":["S0041134505001089"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2005.01.079","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2005,3]]}}}